COPD, Ezetimibe submissions public
August 10, 2016
THE public submissions process
for the post-market reviews of
COPD medicines and Ezetimibe
has now closed, with submissions
addressing the probe’s terms of
enquiry having now been published
on the PBS website.
COPD input was provided by a
range of organisations including
NPS MedicineWise, AstraZeneca,
GlaxoSmithKline, Medicines
Australia, the Asthma Foundation
SA, Lung Foundation Australia,
while Ezetimibe commentators
included Amgen Australia, Sanofi,
Merck Sharp & Dohme and the
Council of Australian Therapeutic
Advisory Groups.
See www.pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Aug 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Aug 16